EP17.02 Third trimester non-invasive evaluation of maternal cardiac function in gestational diabetes
Objectives: To compare maternal hemodynamics measured by non-invasive monitoring between pregnancies complicated by gestational diabetes and healthy controls. Methods: Single centre prospective study. Normotensive women with singleton pregnancy complicated by gestational diabetes were enrolled at gestation beyond 34 weeks and paired with a cohort of uncomplicated pregnancies. Transjugular continuous wave Doppler analysis was undertaken using the semiautomated monitoring device USCOM (UltraSound Cardiac Output Monitor). The evaluation of maternal systolic function included the assessment of the cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke volume variation (SVV), peak-systolic velocity (Vpk), heart rate (HR) and inotropism (INO). Systemic vascular resistance (SVR) could be computed by inserting systolic and diastolic blood pressure in the USCOM algorithm. Results: In all 100 women, of whom 27 diabetic and 73 controls were enrolled for the study purposes. Diabetic women showed significantly higher diastolic and mean blood pressure compared to euglycemic controls (76 ± 10 vs 70 ± 10 mmHg, p 0.016, and 89 ± 11 vs 84 ± 10 mmHg, p 0.032, respectively). No differences between diabetic women and controls were noted in the CO (6.7 ± 1.4 vs 6.4 ± 1.3, p 0.379), CI (3.4 ± 0.7 vs 3.5 ± 0.7, p 0.544), SV, SVV, Vpk, HR, INO and SVR (1139 ± 320 vs 1125 ± 310, p 0.849). Objectives: Primary CMV infection is particularly associated with an adverse outcome if transmission occurs before 20 weeks. Administration of HIG should prevent transmission but the results are contradictory. So far, HIGs are given on a 4 weekly basis. However, we were able to demonstrate an index case with a half-life of about 14 days. In this pilot-study we examine the effectiveness of a HIG on a 2weekly basis in primary CMV infection in the first trimester. Methods: This is an observational study at the University Hospital of Tuebingen between 2013 and 2016. Women with a primary infection ≤14 weeks were included. A recent infection was assumed if <40U/ml, IgM-Index>2, CMV IgG avidity<40%, and without presence of anti-CMV-gB2-IgG. HIG application was started as soon as possible and repeated every 2 weeks. HIG was stopped when CMV-IgG levels were stable > 100U/ml after 2 weeks of the last HIG cycle (Hamprecht et al, 2017) . In all cases, an amniocentesis was performed at around 20 weeks. Amniotic fluid was tested by nested PCR, q-rt-PCR and 18h and 14d cell culture. Results: 20 women fulfilled the inclusion criteria. Serostatus was examined at 11.6 weeks' gestation and HIG application was started at 13.6 weeks, respectively. In 20 cases HIG were administered twice, in 18, 9, 3 and 1 case, HIG was given 3, 4 and 5 times, respectively. Mean gestational age at administration was 15.2, 17.0, 17.8 and 18.4 weeks. Amniocentesis was performed at 20.1 weeks. In none of the cases, we observed transmission. Conclusions: Administration of HIG may play a role in the prevention of first and second trimester transmission if they are given on a 2 weekly basis. Further, larger studies are necessary to confirm this finding.
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